HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

lipoxin B4

structure in first source
Also Known As:
5,14,15-THET; 5,14,15-trihydroxy-6,8,10,12-eicosatetraenoic acid; 5-methyl-LXB4; 5D,14,15L-trihydroxy-6,8,10,12-eicosatetraenoic acid; LXB4; 6,8,10,12-Eicosatetraenoic acid, 5,14,15-trihydroxy-, (SP-4-2)-
Networked: 8 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Karra, L: 1 article (07/2015)
2. Levy, B D: 1 article (07/2015)
3. Priluck, R: 1 article (07/2015)
4. Levi-Schaffer, F: 1 article (07/2015)
5. Haworth, O: 1 article (07/2015)
6. Hu, Shan: 1 article (01/2012)
7. Wu, Gen-Cheng: 1 article (01/2012)
8. Wang, Jun: 1 article (01/2012)
9. Mao-Ying, Qi-Liang: 1 article (01/2012)
10. Wang, Zhi-Fu: 1 article (01/2012)

Related Diseases

1. Inflammation
2. Asthma (Bronchial Asthma)
3. Necrosis
4. Nasal Polyps (Nasal Polyp)
5. Metaplasia

Related Drugs and Biologics

1. lipoxin A4
2. lipoxin B4
3. Lipoxins
4. 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid
5. Leukotriene A4
6. Interleukin-10 (Interleukin 10)
7. Transforming Growth Factor beta (TGF-beta)
8. Interleukin-8 (Interleukin 8)
9. Cytokines
10. Granulocyte Colony-Stimulating Factor (G-CSF)